Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€37.87

€37.87

1.200%
0.45
1.200%
€40.13
 
14:20 / Tradegate WKN: 936718 / Symbol: EXEL / Name: Exelixis / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Exelixis Inc. Stock

There is an upward development for Exelixis Inc. compared to yesterday, with an increase of €0.45 (1.200%).
With 43 Buy predictions and not a single Sell prediction Exelixis Inc. is an absolute favorite of our community.
With a target price of 40 € there is a slightly positive potential of 5.62% for Exelixis Inc. compared to the current price of 37.87 €.
So far the community has only identified positive things for Exelixis Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of Exelixis Inc. in the next few years

Pros
?
G***** c******* t* c**********
?
M***** P*******
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Exelixis Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Exelixis Inc. 1.200% -0.133% -1.240% 78.616% 14.645% 87.984% 76.969%
Ironwood Pharmaceuticals 1.690% 4.202% 12.727% -89.217% -85.238% -94.341% -93.111%
Arrowhead Pharmaceuticals Inc. -0.410% 0.075% -5.125% -44.637% -27.440% -60.048% -65.061%
Novocure Ltd -0.850% 5.331% -10.217% -8.227% -48.094% -77.223% -71.373%

Comments

Prediction Buy
Perf. (%) 0.24%
Target price 45.220
Change
Ends at 30.06.26

Exelixis, Inc. (NASDAQ: EXEL) had its price target raised by analysts at HC Wainwright from $47.00 to $53.00. They now have a "buy" rating on the stock.
Ratings data for EXEL provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 2.47%
Target price 42.780
Change
Ends at 26.06.26

Exelixis, Inc. (NASDAQ: EXEL) was given a new $50.00 price target on by analysts at Jefferies Financial Group Inc.. They now have a "buy" rating on the stock.
Ratings data for EXEL provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -1.28%
Target price 51.762
Change
Ends at 24.06.26

Exelixis, Inc. (NASDAQ: EXEL) was upgraded by analysts at Stephens from an "equal weight" rating to an "overweight" rating. They now have a $60.00 price target on the stock.
Ratings data for EXEL provided by MarketBeat
Show more

News

2 Top Stocks to Buy With Less Than $100: https://g.foolcdn.com/editorial/images/819375/patient-talking-with-a-physician.jpg
2 Top Stocks to Buy With Less Than $100

When investing on a budget, buying fractional shares of top companies is one option. Another is to find stocks with relatively affordable price tags per share. Although it's sometimes the case that

Why Exelixis Stock Is Skyrocketing Today: https://g.foolcdn.com/editorial/images/818283/rocket-drawn-with-ben-franklin-from-100-bill.jpg
Why Exelixis Stock Is Skyrocketing Today

Shares of Exelixis (NASDAQ: EXEL) were skyrocketing 18.5% higher at 11:05 a.m. ET on Wednesday. The huge gain came after the drugmaker announced its 2025 first-quarter results Tuesday evening.

Exelixis Stock: Executives Sell as Shares Near Peak
Exelixis Stock: Executives Sell as Shares Near Peak

Exelixis is experiencing significant insider selling activity while its stock trades near its 52-week high of €37.64. Three high-ranking executives recently reduced their holdings in substantial